Tutkijat / Oulu  | Ala-Kokko, L. |
| Ala-Kokko, T(ero) |
| Ala-Korpela, M(ika) |
| Alahuhta, S. |
| Alén, M(arkku) |
| Antikainen, R. |
| Anttonen, V(uokko) |
| Biancari, F(austo) |
| Bloigu, R(isto) |
| Eskelinen, S. |
| Flinkkilä, T(apio) |
| Hakkola, J. |
| Hallman, M. |
| Hartikainen, A(nna)-L(iisa) |
| Hausen, H. |
| Hautala, N(ina) |
| Hautala, T(imo) |
| Heape, A. |
| Herzig, K(arl)-H(einz) |
| Hillbom, M. |
| Hiltunen, J.K. |
| Hörkko, S. |
| Huikuri, H(eikki) |
| Hukkanen J(anne) |
| Ignatius, J. |
| Isohanni, M. |
| Jaakkola, J. |
| Jaakkola, M(aritta) S. |
| Jaakola, V-P. |
| Jämsä, T(imo) |
| Janhonen, S. |
| Jartti, T(uomas) |
| Järvelin, M(arjo)-R(iitta) |
| Jokelainen, J(ari) |
| Juffer, A.H. |
| Junttila, J(uhani) |
| Juvonen, T. |
| Kaarteenaho, R(iitta) |
| Kajantie, E(ero)*(THL/OY) |
| Karppinen (Koivunen), P(eppi) |
| Karppinen, J(aro) |
| Karttunen, T.J. |
| Keinänen-Kiukaanniemi, S(irkka) |
| Kerkelä, R(isto) |
| Kesäniemi, Y(rjö) A(ntero) |
| Kettunen, J(ohannes) |
| Kietzmann, T(homas). |
| Kivirikko, K.I. |
| Knuuttila, M. |
| Koivukangas, J. |
| Kursula, P. |
| Kyngäs, H. |
| Larivaara, P. |
| Larmas, M. |
| Lehenkari, P(etri) |
| Lehtiö, L(ari) |
| Leppilahti, J. |
| Luukinen, H. |
| Mainio A |
| Majamaa, K. |
| Mäki, P(irjo) |
| Mäkikallio, T(imo) H. |
| Männikkö, M(inna) |
| Manninen, A(ki). |
| Martikainen, H(annu) |
| Miettunen, J(ouko) |
| Myllyharju, J. |
| Myllylä, R. |
| Myllylä, V. |
| Näyhä, S. |
| Neubauer, P. |
| Nieminen, M(iika) T. |
| Nieminen, P(entti) |
| Niinimäki, J(aakko) |
| Ohukainen, P(auli) |
| Oikarinen, A. |
| Oikarinen, K. |
| Pelkonen, O(lavi) |
| Petäjä-Repo, U.E. |
| Pihlajaniemi, T. |
| Pirttiniemi, P(ertti) |
| Puistola, U(lla) |
| Rajaniemi, H.J. |
| Rämet, M(ika) |
| Räsänen, P. |
| Raustia, A. |
| Remes, A(nne) |
| Risteli, J. |
| Ristiniemi, J. |
| Ruddock, L.W. |
| Ruokonen, A. |
| Ruskoaho, H. |
| Ryynänen, M. |
| Saarakkala, S. |
| Saari, A. |
| Salo, T(uula) |
| Sándor, G(eorge) K. |
| Savolainen, E-R. |
| Savolainen, M.J. |
| Savolainen, O. |
| Sillanpää, M(ikko). |
| Soininen, R. |
| Sorri, M. |
| Taanila, A. |
| Tapiainen, T(erhi) |
| Tervonen, O(smo) |
| Timonen, M(arkku) |
| Tjäderhane, L. |
| Turpeenniemi-Hujanen, T. |
| Tuukkanen, J(uha) |
| Tuulonen, A. |
| Uhari, M. |
| Ukkola, O(lavi) |
| Uusimaa, J. |
| Vainio, O. |
| Vainio, S. |
| Väyrynen, J(uha) P. |
| Veijola, J(uha) |
| Veijola, R(iitta) |
| Virokannas, H. |
| Voipio, H(anna)-M(arja) |
| Vuolteenaho, O. |
| Weckström, M. |
| Wei, GH. |
| Wierenga, R.K. |
| Winqvist, R(obert) |
| Ylänne, J. |
| Ylitalo, K(ari) |
Scholar Chart >>
|
»My Articles
»Latest Feeds
»Popular Feeds |
| | Autograft cellular composition and outcome in NHL patients: results of the prospective multicenter GOA study. | Savolainen, E-R. | 192 days | save |  |  |  | |
| CD34+ cell mobilization, blood graft composition, and posttransplant recovery in myeloma patients compared to non-Hodgkin's lymphoma patients: results of the prospective multicenter Goa study. | Savolainen, E-R. | 216 days | save | | | | |
| Hyperthermic intraperitoneal chemotherapy enhances blood coagulation perioperatively evaluated by thromboelastography: a pilot study. | Savolainen, E-R. | 245 days | save | | | | |
| ERCC6L2 defines a novel entity within inherited acute myeloid leukemia. | Savolainen, E-R. | 605 days | save | | | | |
| Placenta-mediated pregnancy complications are not associated with fetal or paternal factor V Leiden mutation. | Savolainen, E-R. | 797 days | save | | | | |
| Blood graft composition and post-transplant recovery in myeloma patients mobilized with plerixafor: a prospective multicenter study. | Savolainen, E-R. | 820 days | save | | | | |
| Thromboelastography Values Remain Hypercoagulative 6 Months After Obesity Surgery: a Pilot Study. | Savolainen, E-R. | 842 days | save | | | | |
| Expression of a specific extracellular matrix signature is a favorable prognostic factor in acute myeloid leukemia. | Savolainen, E-R. | 1071 days | save | | | | |
| Vanin 1 (VNN1) levels predict poor outcome in acute myeloid leukemia. | Savolainen, E-R. | 1151 days | save | | | | |
| Neutrophil CD64, C-reactive protein, and procalcitonin in the identification of sepsis in the ICU - Post-test probabilities. | Savolainen, E-R. | 1171 days | save | | | | |
| Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling. | Savolainen, E-R. | 1200 days | save | | | | |
| Novel non-neutral mitochondrial DNA mutations found in childhood acute lymphoblastic leukemia. | Savolainen, E-R. | 1232 days | save | | | | |
| Intrauterine growth restriction and placental gene expression in severe preeclampsia, comparing early-onset and late-onset forms. | Savolainen, E-R. | 1268 days | save | | | | |
| The impact of sample site and storage on thromboelastography values. | Savolainen, E-R. | 1312 days | save | | | | |
| An extracellular matrix signature in leukemia precursor cells and acute myeloid leukemia. | Savolainen, E-R. | 1321 days | save | | | | |
| Monocyte and lymphocyte surface molecules in severe sepsis and non-septic critically ill Patients. | Savolainen, E-R. | 1378 days | save | | | | |
| Cost analysis of a randomized stem cell mobilization study in multiple myeloma. | Savolainen, E-R. | 1576 days | save | | | | |
| Reply to "Leukocyte receptor expression as a biomarker for severe sepsis". | Savolainen, E-R. | 1795 days | save | | | | |
| The fat mass and obesity-associated (FTO) gene variant rs9939609 predicts long-term incidence of cardiovascular disease and related death independent of the traditional risk factors. | Savolainen, E-R. | 1843 days | save | | | | |
| Kinetics of leukocyte CD11b and CD64 expression in severe sepsis and non-infectious critical care patients. | Savolainen, E-R. | 2055 days | save | | | | |
| The IL-8, VEGF, and CFH Polymorphisms and Bevacizumab in Age-related Macular Degeneration. | Savolainen, E-R. | 2473 days | save | | | | |
| TIM-family molecules in embryonic hematopoiesis: fetal liver TIM-4lo cells have myeloid potential. | Savolainen, E-R. | 2545 days | save | | | | |
| INTERLEUKIN 8 PROMOTER POLYMORPHISM PREDICTS THE INITIAL RESPONSE TO BEVACIZUMAB TREATMENT FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION. | Savolainen, E-R. | 2783 days | save | | | | |
| Transmembrane prolyl 4-hydroxylase is a fourth prolyl 4-hydroxylase regulating EPO production and erythropoiesis. | Savolainen, E-R. | 3003 days | save | | | | |
| The effect of bone marrow microenvironment on the functional properties of the therapeutic bone marrow-derived cells in patients with acute myocardial infarction. | Savolainen, E-R. | 3160 days | save | | | | |
| Cardiac Function, Perfusion, Metabolism, and Innervation following Autologous Stem Cell Therapy for Acute ST-Elevation Myocardial Infarction. A FINCELL-INSIGHT Sub-Study with PET and MRI. | Savolainen, E-R. | 3192 days | save | | | | |
| Left ventricular functional recovery after intracoronary injection of autologous bone marrow-derived stem cells in patients with acute myocardial infarction: A dose-response pilot study. | Savolainen, E-R. | 3283 days | save | | | | |
| Comparison of use of minimized cardiopulmonary bypass with conventional techniques on the incidence of retinal microemboli during aortic valve replacement surgery. | Savolainen, E-R. | 3433 days | save | | | | |
| Analysis of the temperature affects on leukocyte surface antigen expression. | Savolainen, E-R. | 3535 days | save | | | | |
| Minimized cardiopulmonary bypass reduces retinal microembolization: a randomized clinical study using fluorescein angiography. | Savolainen, E-R. | 3629 days | save | | | | |
| Effects of intracoronary infusion of bone marrow-derived stem cells on pulmonary artery pressure and diastolic function after myocardial infarction. | Savolainen, E-R. | 3689 days | save | | | | |
| Effects of intracoronary injection of autologous bone marrow-derived stem cells on natriuretic peptides and inflammatory markers in patients with acute ST-elevation myocardial infarction. | Savolainen, E-R. | 3693 days | save | | | | |
| Prognostic classification of patients with acute lymphoblastic leukemia by using gene copy number profiles identified from array-based comparative genomic hybridization data. | Savolainen, E-R. | 3903 days | save | | | | |
| Determinants of Functional Recovery after Myocardial Infarction of Patients Treated with Bone Marrow Derived Stem Cells after Thrombolytic Therapy. | Savolainen, E-R. | 4021 days | save | | | | |
| Vascular Endothelial Growth Factor Gene Variation and the Response to Photodynamic Therapy in Age-Related Macular Degeneration. | Savolainen, E-R. | 4037 days | save | | | | |
| Polymorphism of the manganese superoxide dismutase gene but not of vascular endothelial growth factor gene is a risk factor for diabetic retinopathy. | Savolainen, E-R. | 4048 days | save | | | | |
| Adiponectin induced placental cell apoptosis could be mediated via the ADIPOR1-receptor in pre-eclampsia with IUGR. | Savolainen, E-R. | 4054 days | save | | | | |
| Quality control of flow cytometry data analysis for evaluation of minimal residual disease in bone marrow from acute leukemia patients during treatment. | Savolainen, E-R. | 4103 days | save | | | | |
| The expression of human resistin in different leucocyte lineages is modulated by LPS and TNFalpha. | Savolainen, E-R. | 4121 days | save | | | | |
| Variation in the vascular endothelial growth factor gene, carotid intima-media thickness and the risk of acute myocardial infarction. | Savolainen, E-R. | 4162 days | save | | | | |
| Acute lymphoblastic leukemias with normal karyotypes are not without genomic aberrations. | Savolainen, E-R. | 4184 days | save | | | | |
| Safety of low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary intracerebral haemorrhage. | Savolainen, E-R. | 4279 days | save | | | | |
| A mutant collagen XIII alters intestinal expression of immune response genes and predisposes transgenic mice to develop B-cell lymphomas. | Savolainen, E-R. | 4335 days | save | | | | |
| Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. | Savolainen, E-R. | 4350 days | save | | | | |
| Cord compression may rapidly influence the expression of placental angiogenic genes in pre-eclampsia. | Savolainen, E-R. | 4478 days | save | | | | |
| CDKN2A deletions in acute lymphoblastic leukemia of adolescents and young adults: an array CGH study. | Savolainen, E-R. | 4519 days | save | | | | |
| The androgen receptor CAG repeat length polymorphism associates with prostate volume in Finnish men with benign prostatic hyperplasia. | Savolainen, E-R. | 4611 days | save | | | | |
| Valproic acid combined with 13-cis retinoic acid and 1,25-dihydroxyvitamin D3 in the treatment of patients with myelodysplastic syndromes. | Savolainen, E-R. | 4770 days | save | | | | |
| Altered expression of angiogenesis-related placental genes in pre-eclampsia associated with intrauterine growth restriction. | Savolainen, E-R. | 4820 days | save | | | | |
| Long-term outcome of intensive chemotherapy for adults with de novo acute myeloid leukaemia (AML): the nationwide AML-92 study by the Finnish Leukaemia Group. | Savolainen, E-R. | 4905 days | save | | | | |
| | 
report | next » | | |
|
